119 related articles for article (PubMed ID: 12122487)
21. Treatment with the selective muscarinic m1 agonist talsaclidine decreases cerebrospinal fluid levels of A beta 42 in patients with Alzheimer's disease.
Hock C; Maddalena A; Raschig A; Müller-Spahn F; Eschweiler G; Hager K; Heuser I; Hampel H; Müller-Thomsen T; Oertel W; Wienrich M; Signorell A; Gonzalez-Agosti C; Nitsch RM
Amyloid; 2003 Mar; 10(1):1-6. PubMed ID: 12762134
[TBL] [Abstract][Full Text] [Related]
22. Enhanced delayed matching performance in younger and older macaques administered the 5-HT4 receptor agonist, RS 17017.
Terry AV; Buccafusco JJ; Jackson WJ; Prendergast MA; Fontana DJ; Wong EH; Bonhaus DW; Weller P; Eglen RM
Psychopharmacology (Berl); 1998 Feb; 135(4):407-15. PubMed ID: 9539266
[TBL] [Abstract][Full Text] [Related]
23. Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys.
Terry AV; Buccafusco JJ; Jackson WJ
Pharmacol Biochem Behav; 1993 Aug; 45(4):925-9. PubMed ID: 8415832
[TBL] [Abstract][Full Text] [Related]
24. The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys.
Ramos BP; Colgan L; Nou E; Ovadia S; Wilson SR; Arnsten AF
Biol Psychiatry; 2005 Dec; 58(11):894-900. PubMed ID: 16043136
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of M1 muscarinic receptors expressed in CHOm1 cells by panaxynol via cAMP pathway.
Hao W; Xing-Jun W; Yong-Yao C; Liang Z; Yang L; Hong-Zhuan C
Neurosci Lett; 2005 Jul 22-29; 383(1-2):121-6. PubMed ID: 15936523
[TBL] [Abstract][Full Text] [Related]
26. Muscarinic agonist-mediated increases in serum corticosterone levels are abolished in m(2) muscarinic acetylcholine receptor knockout mice.
Hemrick-Luecke SK; Bymaster FP; Evans DC; Wess J; Felder CC
J Pharmacol Exp Ther; 2002 Oct; 303(1):99-103. PubMed ID: 12235238
[TBL] [Abstract][Full Text] [Related]
27. Pharmacodynamic profile of the M1 agonist talsaclidine in animals and man.
Wienrich M; Meier D; Ensinger HA; Gaida W; Raschig A; Walland A; Hammer R
Life Sci; 2001 Apr; 68(22-23):2593-600. PubMed ID: 11392631
[TBL] [Abstract][Full Text] [Related]
28. A computer-assisted cognitive test battery for aged monkeys.
Buccafusco JJ; Terry AV; Murdoch PB
J Mol Neurosci; 2002; 19(1-2):179-85. PubMed ID: 12212778
[TBL] [Abstract][Full Text] [Related]
29. A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models.
Hu Y; Xia Z; Sun Q; Orsi A; Rees D
Brain Res; 2005 Oct; 1060(1-2):26-39. PubMed ID: 16226729
[TBL] [Abstract][Full Text] [Related]
30. Actions of alpha-2 noradrenergic agonists on spatial working memory and blood pressure in rhesus monkeys appear to be mediated by the same receptor subtype.
Franowicz JS; Arnsten AF
Psychopharmacology (Berl); 2002 Jul; 162(3):304-12. PubMed ID: 12122489
[TBL] [Abstract][Full Text] [Related]
31. Effects of vinconate on scopolamine-induced memory impairment in rhesus monkeys.
Ando K; Hironaka N; Shuto K
Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Feb; 23(1):43-6. PubMed ID: 12690640
[TBL] [Abstract][Full Text] [Related]
32. Facilitation of memory performance by a novel muscarinic agonist in young and old rats.
Ruske AC; White KG
Pharmacol Biochem Behav; 1999 Aug; 63(4):663-7. PubMed ID: 10462196
[TBL] [Abstract][Full Text] [Related]
33. Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.
Terry AV; Buccafusco JJ; Bartoszyk GD
Psychopharmacology (Berl); 2005 Jun; 179(4):725-32. PubMed ID: 15619109
[TBL] [Abstract][Full Text] [Related]
34. Developmental changes in presynaptic muscarinic modulation of excitatory and inhibitory neurotransmission in rat piriform cortex in vitro: relevance to epileptiform bursting susceptibility.
Whalley BJ; Constanti A
Neuroscience; 2006 Jul; 140(3):939-56. PubMed ID: 16616427
[TBL] [Abstract][Full Text] [Related]
35. Activation of hippocampal postsynaptic muscarinic receptors is involved in long-term spatial memory formation.
Herrera-Morales W; Mar I; Serrano B; Bermúdez-Rattoni F
Eur J Neurosci; 2007 Mar; 25(5):1581-8. PubMed ID: 17355252
[TBL] [Abstract][Full Text] [Related]
36. The 5-HT3 receptor antagonist, RS-56812, enhances delayed matching performance in monkeys.
Terry AV; Buccafusco JJ; Prendergast MA; Jackson WJ; Fontana DL; Wong EH; Whiting RL; Eglen RM
Neuroreport; 1996 Dec; 8(1):49-54. PubMed ID: 9051751
[TBL] [Abstract][Full Text] [Related]
37. Performance- and task-dependent effects of the dopamine D1/D5 receptor agonist SKF 38393 on learning and memory in the rat.
Amico F; Spowart-Manning L; Anwyl R; Rowan MJ
Eur J Pharmacol; 2007 Dec; 577(1-3):71-7. PubMed ID: 17900561
[TBL] [Abstract][Full Text] [Related]
38. The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys.
Webster SJ; Wilson CA; Lee CH; Mohler EG; Terry AV; Buccafusco JJ
Br J Pharmacol; 2011 Oct; 164(3):970-8. PubMed ID: 21486290
[TBL] [Abstract][Full Text] [Related]
39. Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain.
Müller DM; Mendla K; Farber SA; Nitsch RM
Life Sci; 1997; 60(13-14):985-91. PubMed ID: 9121365
[TBL] [Abstract][Full Text] [Related]
40. Dissociation of cholinergic function in spatial and procedural learning in rats.
von Linstow Roloff E; Harbaran D; Micheau J; Platt B; Riedel G
Neuroscience; 2007 May; 146(3):875-89. PubMed ID: 17418958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
